January 6, 2009--Lumenis (Santa Clara, CA), a developer, manufacturer, and seller of laser, light-based, and radiofrequency devices for surgical, aesthetic, and ophthalmic applications, announced U.S. Food and Drug Administration (FDA) approval and market introduction of its new AcuPulse CO2 Laser for gynecology, neurosurgery, general surgery, and aesthetic medicine.
"We are pleased to provide the groundbreaking AcuPulse with the SurgiTouch automation system," said Dov Ofer, Lumenis' CEO. "Physicians can achieve reproducible outcomes at the push of a button by simply selecting the laser application on an intuitive user interface. A mix of animated and real videos can be displayed showing various laser procedures, allowing for quick familiarization across specialties."
With the AcuPulse CO2 laser and SurgiTouch automation system, surgeons can now focus on the surgery--not the laser set-up. Attention has also been paid to the needs of the operating room staff. Video animations display the assembly instructions for various laser accessories, making it simple for new staff to become quickly familiar with the system. "In a busy environment like ours where many nurses rotate between operating rooms, this is an invaluable feature that assure quick readiness of the AcuPulse and improves operating room turn over. In addition, I like its wide range of automated procedures which makes it easy to train my residents", said Marc Remacle, Otolaryngologist, University Hospital of Mont-Godinne (Yvoir, Belgium).
For more information, go to www.lumenis.com.
--Posted by Gail Overton, [email protected].
For first-hand and originally reported business news in the optoelectronics and photonics industry, please subscribe to Optoelectronics Report at www.optoelectronicsreport.com, the twice-monthly eNewsletter from the editors at Laser Focus World and BioOptics World that covers both national and international business news and market trends and tracks technology advances to interpret their business implications.